Eli Lilly has completed the expansion of its biotech facility in San Diego, California. The $90 million expansion has added 180,000 square feet to the 125,000-square-foot campus Lilly moved into in 2009.
Fierce 15 winner C4 Therapeutics has become the latest biopharma to strike a deal with the Google-backed life sciences company Calico, although true to its quiet nature few details about the pact have emerged.
After its venture arm helped raise $31 million for LA-based clinical research company Science 37 last October, Big Pharma Sanofi has now signed its first pact with the company aimed at improving recruitment and reducing trial times with new siteless study tech.
Kaiser Permanente’s telestroke program was first implemented in southern California medical centers between August 2013 and December 2014. Since then the program has proven itself by way of an increase in use of a lifesaving clot-dissolving treatment.